Back to results
US 2014/0005220 A9Published application
Beta carboline derivatives useful in the treatment of proliferative disorders
AssigneesUniversite Libre de Bruxelles, Facultes Universitaires Notre-Dame De La Paix
InventorsRaphael Frederick, Bernard Masereel, Jeremy Reniers, Johan Wouters, Celine Bruyere, Robert Kiss
Life of this patent
Estimating the term…
Abstract
The invention provides novel beta-carboline derivatives of formulae (Ia) and (Ib) useful in the treatment of proliferative disorders including cancer, intermediates used in their preparation, processes for preparing the same and uses thereof.
Claims21
A compound of any one of Formulas (Ia) or (Ib), or stereoisomeric forms thereof,
- wherein
- m is an integer selected from 0, 1 or 2;
- n is an integer selected from 0, 1 or 2;
- L1 is a direct bond, —O—, —S—, —NR8— or —(CR9aR9b)p—;
- and R8 is hydrogen or C1-6alkyl;
- and p is an integer selected from 1, 2, 3, 4, 5 or 6;
- and each R9a and R9b is independently hydrogen, C1-6alkyl, C1-6alkyloxy, C1-6alkylthio, C1-6alkylamino, hydroxy or halo, each group being optionally substituted with one or more substituents independently selected from halo, hydroxy, C1-4alkyloxy or oxo;
- L2 is a direct bond, —O—, —S—, —NR10— or —(CR11aR11b)q—;
- and R19 is hydrogen or C1-6alkyl;
- and q is an integer selected from 1, 2, 3, 4, 5 or 6;
- and each R11a and R11b is independently hydrogen, C1-6alkyl, C1-6alkyloxy, C1-6alkylthio, C1-6alkylamino, hydroxy or halo, each group being optionally substituted with one or more substituents independently selected from halo, hydroxy, C1-4alkyloxy or oxo;
- Z1 is a direct bond, —O—, —S— or —NR12;
- and R12 is hydrogen or C1-6alkyl;
- L3 is a direct bond or —(CR13aR13b)r—;
- and r is an integer selected from 1, 2, 3, 4, 5 or 6;
- and each R13a and R13b is independently hydrogen, C1-6alkyl, C1-6alkyloxy, C1-6alkylthio, C1-6alkylamino, hydroxy or halo, each group being optionally substituted with one or more substituents independently selected from halo, hydroxy, C1-4alkyloxy or oxo;
- Z2 is a direct bond, —O—, —S— or —NR14;
- and R14 is hydrogen or C1-6alkyl;
- L4 is a direct bond or —(CR15aR15b)s—;
- and s is an integer selected from 1, 2, 3, 4, 5 or 6;
- and each R15a and R15b is independently hydrogen, C1-6alkyl, C1-6alkyloxy, C1-6alkylthio, C1-6alkylamino, hydroxy or halo, each group being optionally substituted with one or more substituents independently selected from halo, hydroxy, C1-4alkyloxy or oxo;
- R1 is hydrogen, C1-8alkyl, C2-8alkenyl, C2-8alkynyl, C1-8alkyloxy, C1-8alkylthio, C1-8alkylamino, C3-8cycloalkyl, C3-8cycloalkylC1-6 alkyl, C3-8cycloalkyloxy, C3-8cycloalkylC1-6 alkyloxy, C3-8cycloalkylthio, C3-8cycloalkylC1-6alkylthio, C3-8cycloalkylamino, C3-8cycloalkylC1-6alkylamino, aryl, arylC1-6alkyl, aryloxy, arylC1-6alkyloxy, arylthio, arylC1-6alkylthio, arylamino, arylC1-6alkylamino, heterocyclyl, heterocyclylC1-6alkyl, heterocyclyloxy, heterocyclylC1-6alkyloxy, heterocyclylthio, heterocyclylC1-6alkylthio, heterocyclylamino, heterocyclylC1-6alkylamino, heteroaryl, heteroarylC1-6alkyl;
- heteroaryloxy, heteroarylC1-6alkyloxy, heteroarylthio, heteroarylC1-6alkylthio, heteroarylamino or heteroarylC1-6alkylamino, each group being optionally substituted with one or more substituents independently selected from halo, hydroxy, C1-4alkyl, C1-4alkyloxy, C1-4alkylamino, cyano, nitro or oxo;
- R2 is hydrogen, C1-8alkyl, C2-8alkenyl, C2-8alkynyl, C1-8alkyloxy, C1-8alkylthio, C1-8alkylamino, C3-8cycloalkyl, C3-8cycloalkylC1-6 alkyl, C3-8cycloalkyloxy, C3-8cycloalkylC1-6 alkyloxy, C3-8cycloalkylthio, C3-8cycloalkylC1-6alkylthio, C3-8cycloalkylamino, C3-8cycloalkylC1-6alkylamino, aryl, arylC1-6alkyl, aryloxy, arylC1-6alkyloxy, arylthio, arylC1-6alkylthio, arylamino, arylC1-6alkylamino, heterocyclyl, heterocyclylC1-6alkyl, heterocyclyloxy, heterocyclylC1-6alkyloxy, heterocyclylthio, heterocyclylC1-6alkylthio, heterocyclylamino, heterocyclylC1-6alkylamino, heteroaryl, heteroarylC1-6alkyl, heteroaryloxy, heteroarylC1-6alkyloxy, heteroarylthio, heteroarylC1-6alkylthio, heteroarylamino or heteroarylC1-6alkylamino, each group being optionally substituted with one or more substituents independently selected from halo, hydroxy, C1-4alkyl, C1-4alkyloxy, C1-4alkylamino, cyano, nitro or oxo;
- R3 is hydrogen, C1-8alkyl, C2-8alkenyl, C2-8alkynyl, C1-8alkyloxy, C1-8alkylthio, C1-8alkylamino, C3-8cycloalkyl, C3-8cycloalkylC1-6 alkyl, C3-8cycloalkyloxy, C3-8cycloalkylC1-6 alkyloxy, C3-8cycloalkylthio, C3-8cycloalkylC1-6alkylthio, C3-8cycloalkylamino, C3-8cycloalkylC1-6alkylamino, aryl, arylC1-6alkyl, aryloxy, arylC1-6alkyloxy, arylthio, arylC1-6alkylthio, arylamino, arylC1-6alkylamino, heterocyclyl, heterocyclylC1-6 alkyl, heterocyclyloxy, heterocyclylC1-6alkyloxy, heterocyclylthio, heterocyclylC1-6 alkylthio, heterocyclylamino, heterocyclylC1-6alkylamino, heteroaryl, heteroarylC1-6alkyl, heteroaryloxy, heteroarylC1-6alkyloxy, heteroarylthio, heteroarylC1-6alkylthio, heteroarylamino or heteroarylC1-6alkylamino, each group being optionally substituted with one or more substituents independently selected from halo, hydroxy, C1-4alkyloxy, C1-4alkylamino, cyano, nitro or oxo;
- R4 is hydrogen, C1-8alkyl, C2-8alkenyl, C2-8alkynyl, C1-8alkyloxy, C1-8alkylthio, C1-8alkylamino, C3-8cycloalkyl, C3-8cycloalkylC1-6 alkyl, C3-8cycloalkyloxy, C3-8cycloalkylC1-6 alkyloxy, C3-8cycloalkylthio, C3-8cycloalkylC1-6alkylthio, C3-8cycloalkylamino, C3-8cycloalkylC1-6alkylamino, aryl, arylC1-6alkyl, aryloxy, arylC1-6alkyloxy, arylthio, arylC1-6alkylthio, arylamino, arylC1-6alkylamino, heterocyclyl, heterocyclylC1-6 alkyl, heterocyclyloxy, heterocyclylC1-6alkyloxy, heterocyclylthio, heterocyclylC1-6 alkylthio, heterocyclylamino, heterocyclylC1-6alkylamino, heteroaryl, heteroarylC1-6alkyl, heteroaryloxy, heteroarylC1-6alkyloxy, heteroarylthio, heteroarylC1-6alkylthio, heteroarylamino or heteroarylC1-6alkylamino, each group being optionally substituted with one or more substituents independently selected from halo, hydroxy, C1-4alkyloxy, C1-4alkylamino, cyano, nitro or oxo;
- with the proviso that in formula Ia at least one of R1-L1-, R2-L2-, R3-L3-Z1— or R4-L4-Z2— is not hydrogen and in formula Ib at least one of R2-L2-, R3-L3-Z1— or R4-L4-Z2— is not hydrogen;
- R7 is hydrogen, C1-6alkyl or C1-6alkyloxy, optionally substituted with one or more substituents independently selected from halo, hydroxy, C1-4alkyloxy, aryl or oxo;
- R5 is halo, C1-6alkyl, C1-6alkyloxy, haloC1-6alkyl or haloC1-6alkyloxy;
- R6 is halo, C1-6alkyl, C1-6alkyloxy, haloC1-6alkyl or haloC1-6alkyloxy;
- X− is an organic or inorganic anion;
- or pharmaceutically acceptable addition salts, hydrates or solvates thereof.
29 more elements
A compound of the general formula (VIIa) or (VIIb), or stereoisomeric forms thereof,
- wherein
- x is an integer selected from 0, 1 or 2, preferably x is 0;
- R23 is each independently halo, preferably fluoro;
- R7, R1, L1 and X− have their respective meanings as set forth elsewhere in this specification and
- R1-L1- is preferably benzyl, 2-fluoro-phen-1-ylmethyl or 4-fluoro-phen-1-ylmethyl;
- R7 is preferably methyl;
- X− is preferably halide, more preferably X− is bromide;
- or the pharmaceutically acceptable addition salts, hydrates or solvates thereof.
5 more elements
Dependencies are inferred from the claim text.